Matoke® Pharma welcomes UK Government’s 5-Year AMR Strategy

Matoke® Pharma welcomes the UK Government’s new 5-year national action plan to tackle antimicrobial resistance (AMR), published January 2019. Focus on developing and bringing to market new treatments like Reactive Oxygen® is essential to meeting the global AMR threat. Matoke® welcomes the plan’s commitment to: Shift towards value-based pricing for antimicrobials Make AMR a priority for the Accelerated Access Pathway, … Read More